Cytokines in the acquired immunodeficiency syndrome and other infectious diseases

1995 ◽  
Vol 25 (3) ◽  
pp. 128-134 ◽  
Author(s):  
G. Poli ◽  
E. Vicenzi ◽  
S. Ghezzi ◽  
A. Lazzarin
Keyword(s):  
Infectious Diseases ◽  
Acquired Immunodeficiency Syndrome ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome

Significant Publications on Infectious Diseases Pharmacotherapy in 2017

2018 ◽  
Vol 32 (5) ◽  
pp. 534-545 ◽  
Author(s):  
Erik W. Skoglund ◽  
Kierra M. Dotson ◽  
Casey J. Dempsey ◽  
Christy P. Su ◽  
Farnaz Foolad ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Infectious Diseases ◽  
Acquired Immunodeficiency Syndrome ◽  
Immunodeficiency Virus ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome ◽  
Hiv Aids

Purpose: The most significant peer-reviewed articles pertaining to infectious diseases (ID) pharmacotherapy, as selected by panels of ID pharmacists, are summarized. Summary: Members of the Houston Infectious Diseases Network (HIDN) were asked to nominate peer-reviewed articles that they believed most contributed to the practice of ID pharmacotherapy in 2017, including the areas of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). A list of 33 articles related to general ID pharmacotherapy and 4 articles related to HIV/AIDS was compiled. A survey was distributed to members of the Society of Infectious Diseases Pharmacists (SIDP) for the purpose of selecting 10 articles believed to have made the most significant impact on general ID pharmacotherapy and the single significant publication related to HIV/AIDS. Of 524 SIDP members who responded, 221 (42%) and 95 (18%) members voted for general pharmacotherapy- and HIV/AIDS-related articles, respectively. The highest ranked articles are summarized below. Conclusion: Remaining informed on the most significant ID-related publications is a challenge when considering the large number of ID-related articles published annually. This review of significant publications in 2017 may aid in that effort.

Significant Publications on Infectious Diseases Pharmacotherapy in 2016

2017 ◽  
Vol 31 (5) ◽  
pp. 469-480 ◽  
Author(s):  
Gary Fong ◽  
Erik W. Skoglund ◽  
Kady Phe ◽  
Jessica Guastadisegni ◽  
Katherine M. Shea ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Infectious Diseases ◽  
Acquired Immunodeficiency Syndrome ◽  
Clinical Pharmacists ◽  
Related Article ◽  
Starting Point ◽  
Immunodeficiency Virus ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome ◽  
Hiv Aids

Purpose: This is a summary of the most important articles on infectious diseases (ID) pharmacotherapy published in peer-reviewed literature in 2016 as selected by clinical pharmacists with ID expertise. Summary: The Houston Infectious Diseases Network (HIDN) was asked to identify articles published in peer-reviewed literature in 2016 that were believed to contribute significantly to ID pharmacotherapy, including human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). A list of 46 articles on general ID pharmacotherapy and 8 articles on HIV/AIDS were nominated. Members of the Society of Infectious Diseases Pharmacists (SIDP) were surveyed to select 10 general ID articles believed to have made a significant impact on general ID pharmacotherapy and 1 article most significant to HIV/AIDS pharmacotherapy. Of 445 SIDP members surveyed, 212 (47.6%) and 95 (21.3%) members voted for general ID pharmacotherapy- and HIV/AIDS-related articles, respectively. The 11 highest-ranked papers (10 general ID-related articles and 1 HIV/AIDS-related article) are summarized here. Conclusion: With the large number of ID-related articles published each year, it can be challenging to stay current with the most relevant ID publications. This review of significant publications in 2016 may provide a starting point for that process.

Nasal MRSA Colonization of AIDS Patients Cared for in a Brazilian University Hospital

2001 ◽  
Vol 22 (12) ◽  
pp. 783-785 ◽  
Author(s):  
Maria Clara Padoveze ◽  
Antonia Teresinha Tresoldi ◽  
Angela vonNowakonski ◽  
Francisco Hideo Aoki ◽  
Maria Luiza Moretti Branchini
Keyword(s):  
Staphylococcus Aureus ◽  
Infectious Diseases ◽  
Acquired Immunodeficiency Syndrome ◽  
Genomic Dna ◽  
University Hospital ◽  
Nasal Colonization ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome ◽  
Dna Profiles ◽  
Mrsa Colonization

AbstractWeekly culture surveillance was conducted over a 2-year period to determine the incidence of methicillin-resistantStaphylococcus aureusnasal colonization among acquired immunodeficiency syndrome patients cared for in a day-care unit and in an infectious diseases unit. Analysis of genomic DNA profiles showed a predominant pattern in both units.

scholarly journals Significant Publications on Infectious Diseases Pharmacotherapy in 2020

2021 ◽  
pp. 089719002110404
Author(s):  
Taryn A. Eubank ◽  
Noor Zaidan ◽  
Faris S. Alnezary ◽  
Courtney Moc ◽  
Kelsey Olson ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Infectious Diseases ◽  
Acquired Immunodeficiency Syndrome ◽  
Global Pandemic ◽  
Immunodeficiency Virus ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome ◽  
Hiv Aids

Purpose. To summarize the most highly esteemed, peer-reviewed, infectious diseases (ID) pharmacotherapy articles published in 2020. Summary. Members of the Houston Infectious Diseases Network (HIDN) nominated articles that were deemed to have noteworthy contributions to ID pharmacotherapy in 2020, including those on coronavirus disease 2019 (COVID-19) and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS). To select the most significant articles of 2020, a survey was created and distributed to members of the Society of Infectious Diseases Pharmacists (SIDP) to vote on their top 10 articles of general ID and COVID-19 pharmacotherapy and one noteworthy HIV/AIDS publication. A total of 40 articles were nominated by HIDN: 35 articles pertaining to general ID/COVID-19 pharmacotherapy and 5 articles with HIV/AIDS involvement. Of the 247 SIDP members who responded to the survey, 205 and 42 members voted for general ID/COVID-19 pharmacotherapy articles and HIV/AIDS related articles, respectively. The top publications are summarized. Conclusion. In a taxing year of a global pandemic, the abundant and rapid distribution of ID literature has made it challenging for clinicians to stay informed of significant publications across the ID spectrum. This review summarizes significant ID-related publications in 2020 with the goal of aiding clinicians in staying up to date on the most relevant publications in ID pharmacotherapy.

Biological Agents in Infectious Diseases

1991 ◽  
Vol 4 (5) ◽  
pp. 326-341
Author(s):  
Stan G. Louie ◽  
George S. Jaresko
Keyword(s):  
Infectious Disease ◽  
Immune System ◽  
Infectious Diseases ◽  
Intravenous Immunoglobulin ◽  
Acquired Immunodeficiency Syndrome ◽  
Vaccine Development ◽  
Aids Vaccine ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome ◽  
Near Future

This article examines the use of classical as well as novel immunological agents to augment the immune system. Strategies to prevent infectious disease using vaccines to prime the immune system are discussed. A prospective overview of acquired immunodeficiency syndrome (AIDS) vaccine development provides insights into the possible agents that may be developed in the near future. The rationale for the use of intravenous immunoglobulin and colony stimulating factors in selected clinical situations is also discussed.

Sign in / Sign up

Export Citation Format

Share Document